Drug Prices
Prescription Drug Importation Fuels More Questions than Answers
Drug Prices
Prescription Drug Importation Fuels More Questions than Answers

'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
Drug Prices
‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers

President Trump’s 'Most Favored Nation' Executive Order Won’t Lower Drug Prices Immediately
Drug Prices
President Trump’s ‘Most Favored Nation’ Executive Order Won’t Lower Drug Prices Immediately

Analysis: U.S. Pays Substantially More than Australia for the Same Prescription Drugs
Drug Prices
Analysis: U.S. Pays Substantially More than Australia for the Same Prescription Drugs

Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices

In Pandemic, Pharma Attempts an Image Reset — But Americans Still Want Pricing Reform
Drug Prices
In Pandemic, Pharma Attempts an Image Reset — But Americans Still Want Pricing Reform

'Canary in a Coal Mine': Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs
Drug Prices
‘Canary in a Coal Mine’: Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs

'Buy American' Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
Drug Prices
‘Buy American’ Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
Explainer

A Letter to CMS on the Proposed Medicaid Rule
Drug Prices
A Letter to CMS on the Proposed Medicaid Rule

Executive Orders Unlikely to Lower Drug Prices
Drug Prices
Executive Orders Unlikely to Lower Drug Prices

To Lower Drug Costs, Tap Pharmacists for Help
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help

Gilead Sets Two Separate Prices for its COVID-19 Drug in the United States, Charging More to Treat Most Americans
Drug Prices
Gilead Sets Two Separate Prices for its COVID-19 Drug in the United States, Charging More to Treat Most Americans

A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old

Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic
Drug Prices
Study: Blocking Generic Drugs is a Costly and Common Pharma Tactic
$761 million
COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain
Drug Prices
COVID-19 Reveals Fissures in the Nation’s Prescription Drug Supply Chain

Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Drug Prices
Why Nonprofit Pharma, a Promising Fix for Drug Prices, Faces an Uphill Battle
Four Key Moments from Trump's State of the Union Address
Community Supervision
Four Key Moments from Trump’s State of the Union Address

Video: An 'Erosion' of Protection: The State of Health Care in America
Drug Prices
Video: An ‘Erosion’ of Protection: The State of Health Care in America
As Democrats Debate in Des Moines, Health Care Reform Tops Iowans' Wish Lists
Drug Prices
As Democrats Debate in Des Moines, Health Care Reform Tops Iowans’ Wish Lists

A Small Win on Drug Pricing Was Added to the U.S. Budget, but Does it Go Far Enough?
Drug Prices
A Small Win on Drug Pricing Was Added to the U.S. Budget, but Does it Go Far Enough?

Laboratories of Democracy: States Ring in New Year with Ambitious New Health Laws
Drug Prices
Laboratories of Democracy: States Ring in New Year with Ambitious New Health Laws

A Landmark Drug Pricing Bill Just Cleared the House. Now What?
Drug Prices
A Landmark Drug Pricing Bill Just Cleared the House. Now What?

About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
- Criminal Justice
- Evidence-Based Policy
- Contraceptive Choice and Access
- Gun Policy Research
- Policing
- Complex Care
- Drug Prices
- Higher Education